


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-9.31%
+4.40%
-0.68%
+1.29%
PRME
Prime Medicine Inc.
$3.35
Chart
$5.65 (-40.71%)
$3.57 (-6.16%)
$1.83 (+83.06%)
$2.97 (+12.79%)
PRME has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

PRME overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
PRME Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PRME Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is PRME current stock price?
What are PRME stock strengths?
What risks are associated with PRME stock?
When is PRME next earnings report?
What is PRME market cap and volume?
What is PRME's current Stock IQ?
Should I buy PRME stock right now?
Is PRME a Strong Buy right now?
What does a 'Strong Buy' rating mean for PRME?
What does a 'Strong Sell' rating mean for PRME?
What factors influence PRME's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-9.31%
+4.40%
-0.68%
+1.29%
PRME
Prime Medicine Inc.
Current Price
$3.35

Chart
$5.65 (-40.71%)
$3.57 (-6.16%)
$1.83 (+83.06%)
$2.97 (+12.79%)
PRME Analysts Opinion
PRME Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
PRME Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PRME Street Sentiment is bullish and have negative views on the near-term outlook
PRME has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels.
PRME Latest Analysis
Prime Medicine to Present at Jefferies Global Healthcare Conference. CAMBRIDGE Mass. Nov. 11 2025 (GLOBE NEWSWIRE) -- Prime Medicine Inc. (Nasdaq: PRME) a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies today announced that Allan Reine M.D. Chief Executive Officer of Prime Medicine will participate in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday November 18 2025 at 12:00 noon GMT (7:00 a.m. ET) in London
Tue Nov 11, 2025
Prime Medicine GAAP EPS of -$0.32 misses by $0.06 revenue of $1.2M misses by $1.6M.
Fri Nov 7, 2025
Prime Medicine Appoints Matthew Hawryluk Ph.D. M.B.A. as Chief Business Officer. CAMBRIDGE Mass. Nov. 03 2025 (GLOBE NEWSWIRE) -- Prime Medicine Inc. (Nasdaq: PRME) a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies today announced the appointment of Matthew Hawryluk Ph.D. M.B.A. as Chief Business Officer (CBO). Dr. Hawryluk will lead Primes corporate and business development initiatives corporate strategy and alliance management fun
Mon Nov 3, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PRME Stock trends
PRME Stock performance
PRME Stock analysis
PRME investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.